After one and a half year of Health Canada’s approval of the sale of Mifegymiso, the abortion-inducing medication is now available at a few clinics in Canada.
Mifegymiso is a combination of two drugs taken on separate days.It is a two-step abortion process, which involves taking separate medications: mifepristone blocks the hormone progesterone; misoprostol induces a miscarriage.
It’s approved for use by women in the first seven weeks of pregnancy in Canada.
It took the federal agency three years to approve the drug, an unusually long time, though this medicine is included in World Health Organization’s List of Essential Medicines.
Celopharma, the Canadian distributor of Mifegymiso is asking Health Canada to allow pharmacists to dispense Mifegymiso to patients directly like other prescription drugs, instead of requiring physicians to dispense it.